Φορτώνει......
FGF21 improves glucose homeostasis in an obese diabetes-prone mouse model independent of body fat changes
AIMS/HYPOTHESIS: Fibroblast growth factor 21 (FGF21) is considered to be a promising therapeutic candidate for the treatment of type 2 diabetes. However, as FGF21 levels are elevated in obese and diabetic conditions we aimed to test if exogenous FGF21 is sufficient to prevent diabetes and beta cell...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Diabetologia |
|---|---|
| Κύριοι συγγραφείς: | , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Springer Berlin Heidelberg
2017
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6448882/ https://ncbi.nlm.nih.gov/pubmed/28770320 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00125-017-4389-x |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|